Forward Pharma A/S is a biotechnology business based in the US. Forward Pharma A/S shares (FWP) are listed on the NASDAQ and all prices are listed in US Dollars. Forward Pharma A/S employs 4 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Forward Pharma A/S
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – FWP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- FWP shares summary
- Compare share dealing platforms
- Is FWP stock a buy or sell?
- Stock performance over time
- Can I short FWP shares?
- Are FWP shares over-valued?
- Forward Pharma A/S's financials
- How volatile are FWP shares?
- Does Forward Pharma A/S pay a dividend?
- Have FWP shares ever split?
- Other common questions
Forward Pharma A/S stock price (NASDAQ: FWP)Use our graph to track the performance of FWP stocks over time.
Forward Pharma A/S shares at a glance
|Latest market close||$6.60|
|52-week range||$5.76 - $20.31|
|50-day moving average||$7.02|
|200-day moving average||$7.97|
|Wall St. target price||$37.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.84|
Buy Forward Pharma A/S shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Forward Pharma A/S stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Forward Pharma A/S price performance over time
|1 week (2021-10-08)||5.94%|
|1 month (2021-09-16)||8.20%|
|3 months (2021-07-16)||-40.22%|
|6 months (2021-04-15)||-5.85%|
|1 year (2020-10-15)||2.17%|
|2 years (2019-10-15)||570.53%|
|3 years (2018-10-15)||212.80%|
|5 years (2016-10-14)||20.2|
Is Forward Pharma A/S under- or over-valued?
Valuing Forward Pharma A/S stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Forward Pharma A/S's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Forward Pharma A/S's PEG ratio
Forward Pharma A/S's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.13. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Forward Pharma A/S's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Forward Pharma A/S financials
|Gross profit TTM||$0|
|Return on assets TTM||-2.62%|
|Return on equity TTM||-6.94%|
|Market capitalisation||$43.7 million|
TTM: trailing 12 months
Shorting Forward Pharma A/S shares
There are currently 26,503 Forward Pharma A/S shares held short by investors – that's known as Forward Pharma A/S's "short interest". This figure is 16.8% up from 22,688 last month.
There are a few different ways that this level of interest in shorting Forward Pharma A/S shares can be evaluated.
Forward Pharma A/S's "short interest ratio" (SIR)
Forward Pharma A/S's "short interest ratio" (SIR) is the quantity of Forward Pharma A/S shares currently shorted divided by the average quantity of Forward Pharma A/S shares traded daily (recently around 265030). Forward Pharma A/S's SIR currently stands at 0.1. In other words for every 100,000 Forward Pharma A/S shares traded daily on the market, roughly 100 shares are currently held short.
However Forward Pharma A/S's short interest can also be evaluated against the total number of Forward Pharma A/S shares, or, against the total number of tradable Forward Pharma A/S shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Forward Pharma A/S's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Forward Pharma A/S shares in existence, roughly 0 shares are currently held short) or 0.0164% of the tradable shares (for every 100,000 tradable Forward Pharma A/S shares, roughly 16 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Forward Pharma A/S.
Find out more about how you can short Forward Pharma A/S stock.
Forward Pharma A/S share dividends
We're not expecting Forward Pharma A/S to pay a dividend over the next 12 months.
Have Forward Pharma A/S's shares ever split?
Forward Pharma A/S's shares were split on a 1:7 basis on 5 December 2019. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Forward Pharma A/S shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Forward Pharma A/S shares which in turn could have impacted Forward Pharma A/S's share price.
Forward Pharma A/S share price volatility
Over the last 12 months, Forward Pharma A/S's shares have ranged in value from as little as $5.76 up to $20.31. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Forward Pharma A/S's is 1.7513. This would suggest that Forward Pharma A/S's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Forward Pharma A/S overview
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was incorporated in 2005 and is headquartered in Copenhagen, Denmark. .
Forward Pharma A/S in the news
Ampio Pharmaceuticals Strengthens Management Team and Board of Directors
GH Research PLC Provides Business Updates and Reports Second Quarter 2021 Financial Results
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
Frequently asked questionsWhat percentage of Forward Pharma A/S is owned by institutions?
Currently 11.37% of Forward Pharma A/S shares are held by institutions. How many people work for Forward Pharma A/S?
Latest data suggests 4 work at Forward Pharma A/S. When does the fiscal year end for Forward Pharma A/S?
Forward Pharma A/S's fiscal year ends in December. Where is Forward Pharma A/S based?
Forward Pharma A/S's address is: Oestergade 24A, Copenhagen, Denmark, 1100 What is Forward Pharma A/S's ISIN number?
Forward Pharma A/S's international securities identification number is: US34986J2042 What is Forward Pharma A/S's CUSIP number?
Forward Pharma A/S's Committee on Uniform Securities Identification Procedures number is: 34986J105
More guides on Finder
How to buy Aura Biosciences (AURA) stock when it goes public
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
How to buy Claros Mortgage Trust (CMTG) stock when it goes public
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
How to buy Evotec SE (EVO) stock when it goes public
Everything we know about the Evotec SE IPO, plus information on how to buy in.
How to buy Delimobil Holding SA (DMOB) stock when it goes public
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
How to buy Blue Water Vaccines (BWV) stock when it goes public
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
How to buy Sonendo (SONX) stock when it goes public
Everything we know about the Sonendo IPO, plus information on how to buy in.
How to buy FlexEnergy Green Solutions (FLXE) stock when it goes public
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
How to buy Stran & Company (STRN) stock when it goes public
Everything we know about the Stran & Company IPO, plus information on how to buy in.
How to buy Kidpik Corp (PIK) stock when it goes public
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
How to buy Nuvectis Pharma (NVCT) stock when it goes public
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
Ask an Expert